Sign in

CIK 0001678660

  • Non-accelerated filer
  • Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811384762
Phone
+1 302-467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −619,850 0
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −413,234 0
2020-09-29 ORBIMED ADVISORS LLC Director Conversion · Non-Voting Common Stock +5,555,186 5,555,186
2020-09-29 Dier Mardi Director Purchase +10,000 $19.00 $190K 10,000
2020-09-29 Morosini Deborah EVP, Chief of Clinical Affairs Purchase +444 $19.00 $8K 444
2020-09-29 Pierce Christopher EVP and Chief of Business Oper Purchase +3,750 $19.00 $71K 3,750
2020-09-29 Vaddi Krishna President, CEO Conversion +101,477 101,477
2020-09-29 Vaddi Krishna President, CEO Conversion +32,876 551,776
2020-09-29 Vaddi Krishna President, CEO Conversion +32,876 551,774
2020-09-29 Vaddi Krishna President, CEO Conversion · Series A Preferred Stock −101,477 0
2020-09-29 Vaddi Krishna President, CEO Conversion · Series A Preferred Stock −32,876 0
2020-09-29 Vaddi Krishna President, CEO Conversion · Series A Preferred Stock −32,876 0
2020-09-25 Bonita David P Director Purchase +526,300 $19.00 $10.0M 526,300
2020-09-25 Bonita David P Director Purchase +710,500 $19.00 $13.5M 917,412
2020-09-25 ORBIMED ADVISORS LLC Director Purchase +526,300 $19.00 $10.0M 526,300
2020-09-25 ORBIMED ADVISORS LLC Director Purchase +710,500 $19.00 $13.5M 917,412
2020-09-24 BAKER BROS. ADVISORS LP Director Grant or award · Non-Qualified Stock Option (right to buy) +46,688 46,688
2020-09-24 Bonita David P Director Grant or award · Director Stock Option (right to buy) +46,688 46,688
2020-09-24 Sandor Victor Director Grant or award · Director Stock Option (right to buy) +3,458 3,458
2020-09-24 Dier Mardi Director Grant or award · Director Stock Option (right to buy) +3,458 3,458

Page 18 of 19 · 369 trades